Cardinal Health Inc (NYSE:CAH) Shares Bought by IMS Capital Management

IMS Capital Management lifted its position in Cardinal Health Inc (NYSE:CAH) by 104.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,823 shares of the company’s stock after acquiring an additional 7,057 shares during the quarter. IMS Capital Management’s holdings in Cardinal Health were worth $652,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. AI Financial Services LLC boosted its position in Cardinal Health by 2.9% during the 3rd quarter. AI Financial Services LLC now owns 54,477 shares of the company’s stock valued at $2,571,000 after purchasing an additional 1,551 shares during the period. Cerebellum GP LLC acquired a new position in Cardinal Health during the 3rd quarter valued at approximately $129,000. Advantage Investment Management LLC acquired a new position in Cardinal Health during the 3rd quarter valued at approximately $31,000. Trilogy Capital Inc. boosted its position in Cardinal Health by 5.7% during the 3rd quarter. Trilogy Capital Inc. now owns 16,732 shares of the company’s stock valued at $771,000 after purchasing an additional 898 shares during the period. Finally, Thomasville National Bank acquired a new position in Cardinal Health during the 3rd quarter valued at approximately $809,000. Institutional investors own 90.20% of the company’s stock.

CAH stock traded up $0.34 during trading on Wednesday, reaching $45.30. 1,848,993 shares of the company’s stock were exchanged, compared to its average volume of 2,959,238. The company has a quick ratio of 0.54, a current ratio of 1.07 and a debt-to-equity ratio of 1.20. Cardinal Health Inc has a 1-year low of $41.03 and a 1-year high of $58.31. The company’s fifty day moving average price is $45.71 and its 200-day moving average price is $46.01. The firm has a market cap of $13.21 billion, a PE ratio of 8.58, a P/E/G ratio of 1.53 and a beta of 1.32.



Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, August 8th. The company reported $1.11 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.93 by $0.18. Cardinal Health had a return on equity of 25.96% and a net margin of 0.94%. The company had revenue of $37.35 billion during the quarter, compared to analyst estimates of $36.70 billion. During the same quarter in the previous year, the firm posted $1.01 EPS. The firm’s quarterly revenue was up 5.7% on a year-over-year basis. As a group, sell-side analysts expect that Cardinal Health Inc will post 4.99 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, October 1st will be given a dividend of $0.4811 per share. The ex-dividend date is Monday, September 30th. This represents a $1.92 dividend on an annualized basis and a yield of 4.25%. Cardinal Health’s dividend payout ratio (DPR) is presently 36.36%.

A number of research analysts recently issued reports on the company. Morgan Stanley reduced their price objective on Cardinal Health from $50.00 to $41.00 and set an “underweight” rating for the company in a research report on Friday, September 6th. Deutsche Bank assumed coverage on Cardinal Health in a research report on Thursday, September 12th. They set a “hold” rating and a $50.00 price objective for the company. Argus lowered Cardinal Health from a “buy” rating to a “hold” rating in a research report on Tuesday, August 27th. ValuEngine upgraded Cardinal Health from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 2nd. Finally, Guggenheim set a $55.00 price target on Cardinal Health and gave the stock a “buy” rating in a research report on Thursday, September 12th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and one has issued a buy rating to the company’s stock. Cardinal Health has a consensus rating of “Hold” and an average target price of $53.63.

About Cardinal Health

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

Read More: Trade War

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.